While artificial intelligence may be useful for a variety of purposes – including asking silly questions we're afraid to pose in real life – the ultimate end game for digital intelligence could be ...

The medical device maker's growth rate has averaged less than 2% in the past five years. However, it's still innovating and recently launched an AI-assisted endoscopy system.

Medtronic is a healthcare technology company that has seen encouraging growth in the current fiscal year. The company has maintained pricing power and has a strong balance sheet, with an A+ grade f...

Medtronic is undervalued compared to its long-term P/E ratio and has potential for strong returns. The company's focus on innovation and product diversification positions it well for future growth.

Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.

In the closing of the recent trading day, Medtronic (MDT) stood at $83.92, denoting a -1.27% change from the preceding trading day.

Medtronic (MDT) announces the FDA approval of the newest-generation Evolut TAVR system for the treatment of symptomatic severe aortic stenosis.

Healthcare expenses tend to rise year after year regardless of what's happening to the overall economy. Medtronic has a 46-year history of consecutive annual dividend raises.

The AI-in-healthcare market is expanding in the double digits and could reach more than $148 billion by the end of the decade. Nvidia CEO Jensen Huang says AI may have the most impact in the health...

Medtronic and Merck are innovative healthcare leaders. Both are developing new products to keep sales growing.

“Higher for longer” may prove true as sticky inflation indicates the higher-rate environment might be here to stay. As interest rates stay steady, risk-averse investors gravitate towards short-term...

Medtronic plc (MDT) Management presents at 2024 Barclays 26th Annual Healthcare Conference (Transcript)

Medtronic is a healthcare behemoth, developing and manufacturing medical devices for chronic diseases, with a broad and dominant portfolio of industry-leading products. The company has increased it...

Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.